Phenylpiperazine

Phenylpiperazine

SCHEMBL55125

c1ccc(N2CCNCC2)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB1 P08588 6/20 1.00
HTR3E A5X5Y0 5/20 1.00
HTR3B O95264 5/20 1.00
HTR3A P46098 5/20 1.00
HTR3D Q70Z44 5/20 1.00
HTR3C Q8WXA8 5/20 1.00
SIGMAR1 Q99720 5/20 1.00
HTR1A P08908 2/20 0.68
HTR7 P34969 2/20 0.68
LTA4H P09960 1/20 0.68
USP2 O75604 2/20 0.64
CYP2D6 P10635 2/20 0.64
HTR6 P50406 3/20 0.63
TSHR P16473 2/20 0.63
ALDH1A1 P00352 1/20 0.63
HSD17B10 Q99714 1/20 0.63
ADRB2 P07550 1/20 0.61
NCF1 P14598 1/20 0.61
PLD1 Q13393 1/20 0.61
HTR2C P28335 2/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phenylpiperazine SCHEMBL27858598 1.00 ADRB1 (1.00) ADRB1HTR3EHTR3BHTR3AHTR3D
Phenylpiperazine SCHEMBL24889 1.00 ADRB1 (1.00) ADRB1HTR3EHTR3BHTR3AHTR3D
Phenylpiperazine SCHEMBL29135595 1.00 ADRB1 (1.00) ADRB1HTR3EHTR3BHTR3AHTR3D
Phenylpiperazine SCHEMBL11430796 0.98 ADRB1 (0.95) ADRB1HTR3EHTR3BHTR3AHTR3D
SCHEMBL17431870 0.98 ADRB1 (0.95) ADRB1HTR3EHTR3BHTR3AHTR3D
Phenylpiperazine SCHEMBL212247 0.98 ADRB1 (0.95) ADRB1HTR3EHTR3BHTR3AHTR3D
SCHEMBL7934360 0.98 ADRB1 (0.95) ADRB1HTR3EHTR3BHTR3AHTR3D
Phenylpiperazine SCHEMBL10675573 0.98 ADRB1 (0.95) ADRB1HTR3EHTR3BHTR3AHTR3D
Phenylpiperazine SCHEMBL15327472 0.98 ADRB1 (0.95) ADRB1HTR3EHTR3BHTR3AHTR3D
Phenylpiperazine SCHEMBL2973134 0.98 ADRB1 (0.95) ADRB1HTR3EHTR3BHTR3AHTR3D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 933 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117986271-A Cell cycle regulator, and pharmaceutical preparation and application thereof 贵州大学 2024-05-07 CN claimed
CN-116768862-A Indole pyrazole compound as well as preparation method and application thereof 郑州大学 2023-09-19 CN claimed
CN-115677577-A Small molecular compound targeting SRSF6 protein, and preparation method and application thereof 中国药科大学 2023-02-03 CN claimed
CN-114751901-A 9-N-aminoalkyl-13-alkyl (-8, 9-cyclization) berberine derivative and preparation method and application thereof 南京中医药大学 2022-07-15 CN claimed
CN-114466913-A Dihydroquinoline photochromic compounds 光学转变有限公司 2022-05-10 CN claimed
CN-114105908-A Preparation method of key intermediate of tetrahydronaphthalene benzamide 辽宁大学 2022-03-01 CN claimed
US-11234987-B2 Isoxazole compounds as inhibitors of heat shock proteins CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2022-02-01 US claimed
US-10413550-B2 Isoxazole compounds as inhibitors of heat shock proteins THE INSTITUTE OF CANCER RESEARCH (GB) 2019-09-17 US claimed
US-20170088518-A1 Fluorinated Derivatives of 3-Hydroxypyridin-4-Ones THE BANK OF NOVA SCOTIA (CA) 2017-03-30 US claimed
US-9446021-B2 Derivatives of fluorene, anthracene, xanthene, dibenzosuberone and acridine and uses thereof DOGWOOD PHARMACEUTICALS, INC. (US) 2016-09-20 US claimed
US-4342764-A Guanidine compounds, pharmaceutical compositions and use CIBA-GEIGY CORPORATION (US) 1982-08-03 US claimed
EP-0054974-A1 Imidazolylpropanol compounds and their acid addition salts, and production and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1982-06-30 EP claimed
EP-0050916-A2 CNS stimulants and antihypertensive agents AMERICAN HOME PRODUCTS CORPORATION (US) 1982-05-05 EP claimed
US-4324897-A 1,2,3 Oxadiazolium salts AMERICAN HOME PRODUCTS CORPORATION (US) 1982-04-13 US claimed
US-4289885-A 3-[2-(Dimethylamino)-2-phenylethyl]N-[phenylamino)carbonyl]sydnone imine, a new central nervous system stimulant AMERICAN HOME PRODUCTS CORPORATION (US) 1981-09-15 US claimed
EP-0020304-A1 Guanidines, process for their preparation, pharmaceutical preparations containing such compounds and their application CIBA-GEIGY AG (CH) 1980-12-10 EP claimed
US-4208325-A Preparation of 1-oxapenicillins and 4-acyloxy azetidinone intermediates therefor QUEEN'S UNIVERSITY AT KINGSTON (CA) 1980-06-17 US claimed
US-4112105-A Anti-inflammatory 3-(substituted-amino)-2,1-benzisothiazoles STERLING DRUG INC. (US) 1978-09-05 US claimed
US-4018782-A 1-OXAPENICILLINS, ANTIBIOTICS QUEEN'S UNIVERSITY (CA) 1977-04-19 US claimed
US-3994890-A TRANQUILIZERS, ANTIDEPRESSANTS, ANTIINFLAMMATORY CHUGAI SEIYAKU KABUSHIKI KAISHA (JA) 1976-11-30 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10413550-B2 Isoxazole compounds as inhibitors of heat shock proteins HSP90AB1, HSP90AA1, HSP90AB2P ADRB1 361/4885HTR3E 3279/4885HTR3B 3029/4885
US-11234987-B2 Isoxazole compounds as inhibitors of heat shock proteins HSP90AB1, HSP90AA1, HSP90AB2P ADRB1 333/4885HTR3E 3230/4885HTR3B 3028/4885
US-20170088518-A1 Fluorinated Derivatives of 3-Hydroxypyridin-4-Ones FH, FECH, FPGS ADRB1 4126/4885HTR3E 529/4885HTR3B 484/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.